EFFICACY OF TEZEPELUMAB IN PATIENTS WITH LOW AND HIGH BRONCHODILATOR REVERSIBILITY IN PATHWAY

被引：0
|
作者：
Corren, J. [1 ]
Liu, M. C. [2 ]
Bowen, K. [3 ]
Salapa, K. [4 ]
Colice, G. [3 ]
Llanos-Ackert, J. P. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, Warsaw, Poland
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2020-BTSabstracts.144
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S139
引用
收藏
页码：A83 / A84
页数：2
相关论文
共 50 条
  • [21] Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction
    Israel, Elliot
    Castro, Mario
    Ambrose, Christopher S.
    Llanos, Jean-Pierre
    Molfino, Nestor A.
    Martin, Nicole L.
    Ponnarambil, Sandhia S.
    Martin, Neil
    ERJ OPEN RESEARCH, 2024, 10 (06)
  • [22] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and Fungal Sensitization
    Corren, Jonathan
    Mathur, Sameer K.
    Carr, Tara F.
    Wardlaw, Andrew J.
    Caminati, Marco
    Martin, Nicole
    Ponnarambil, Sandhia
    Lindsley, Andrew W.
    Spahn, Joseph D.
    Martin, Neil
    Geffen, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB97 - AB97
  • [23] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy
    Corren, Jonathan
    Ambrose, Christopher S.
    Salapa, Kinga
    Roseti, Stephanie L.
    Griffiths, Janet M.
    Parnes, Jane R.
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4334 - +
  • [24] EFFICACY OF TEZEPELUMAB IN HISPANIC OR LATINO PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
    Hill, J.
    Carr, T.
    Ambrose, C.
    Martin, N.
    Ponnarambil, S.
    Lindsley, A.
    Martin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S35 - S35
  • [25] Study on factors associated with post bronchodilator reversibility among patients presenting with dyspnea
    Vinod, V. G.
    LUNG INDIA, 2023, 40 (01) : 97 - 97
  • [26] TEZEPELUMAB EFFICACY IN SEVERE ASTHMA BY SPECIFIC ALLERGEN SENSITIVITY: RESULTS FROM THE PATHWAY STUDY
    Corren, J.
    Ambrose, C.
    Salapa, K.
    Parnes, J.
    Colice, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S5 - S6
  • [27] Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD
    O'Donnell, D. E.
    Laveneziana, P.
    Ora, J.
    Webb, K. A.
    Lam, Y-M
    Ofir, D.
    THORAX, 2009, 64 (03) : 216 - 223
  • [28] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA WITH COMORBID GASTROESOPHAGEAL REFLUX DISEASE: A POOLED ANALYSIS OF THE PATHWAY AND NAVIGATOR STUDIES
    Moore, Wendy C.
    Lugogo, Njira L.
    Chupp, Geoffrey L.
    Martin, Nicole
    Ambrose, Christopher
    Cook, William
    Ackert, Jean-Pierre Llanos
    CHEST, 2023, 164 (04) : 4A - 7A
  • [29] Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials
    Corren, Jonathan
    Menzies-Gow, Andrew
    Chupp, Geoffrey
    Israel, Elliot
    Korn, Stephanie
    Cook, Bill
    Ambrose, Christopher S.
    Hellqvist, Asa
    Roseti, Stephanie L.
    Molfino, Nestor A.
    Llanos, Jean-Pierre
    Martin, Neil
    Bowen, Karin
    Griffiths, Janet M.
    Parnes, Jane R.
    Colice, Gene
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (01) : 13 - 24
  • [30] Efficacy of tezepelumab in patients with severe, uncontrolled asthma and low blood eosinophil counts not receiving maintenance oral corticosteroids
    Menzies-Gow, A.
    Cook, B.
    Colice, G.
    Hellqvist, A.
    Llanos-Ackert, J. P.
    Ambrose, C. S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345